Functional Mobility Assessment (FMA) Outcomes Program


The Functional Mobility Assessment (FMA) Outcomes Program is a tool that is used to gauge consumers’ abilities to function using rehab equipment on self-reported assessments. The FMA measures patient satisfaction and ability to perform Mobility-Related Activities of Daily Living (MRADLs) by comparing their new equipment to their old equipment. 

Created in partnership with the University of Pittsburgh, the FMA is meant to show that the most appropriate equipment provided by quality ATPs, PTs, or OTs , along with tracked care plans, increases positive outcomes and reduces the future cost of care per client. With better care, clients have better health and better outcomes. 

Benefits of the FMA: 

Improved Consumer Outcomes

The data that has been collected shows that proper rehab products and services provided by quality ATPs help keep patients out of the hospital, reduce wound frequency, and lower the number of patient falls. 

Data Can Support the Industry 

Growing this national database will create a pool of data to support insurance contracts, workers’ compensations contracts, and it defends CRT pricing and the importance of ATPs with vetted, quantified data with CMS/policy-makers. 

Distinguish Company with Referral Sources to Gain Incremental Business

U.S. Rehab will provide participants with their results in a standard report after a certain amount of data is collected, which can be used for internal QA programs and company policies for accreditation purposes.

Be Proactive as Payers Continue to Focus on Value-Based Care, Making Outcomes Reporting a Requirement

Providers will possess outcomes data before the insurance companies and CMS require it. 

It is the industry’s duty to make payers realize that proper equipment & tracked care plans reduce the future cost of care per client. To keep the CRT industry viable, providers must move towards an outcomes-based health care system. 

To learn more, click here.



FMA In the News:

Funding & The Functional Mobility Assessment: Q&A With Greg Packer, U.S. Rehab
Greg Packer, president of U.S. Rehab, on why it’s critical to prove the efficacy of complex rehab technology (CRT).

Quality Assurance & The Functional Mobility Assessment
The industry knows Complex Rehab Technology improves lives. Proving it does has been decades in the making.

Quality Assurance & The FMA: What Clients Say About CRT
Does complex rehab technology (CRT) work? Do the interventions of clinicians, rehabilitation technology suppliers and highly customized, individually fitted seating and wheeled mobility systems improve outcomes for clients? With quality assurance results from the Functional Mobility Assessment (FMA) now being published, the answer is yes.

Quality Assurance & The FMA: Secondary Health Conditions & Environments
Clients say they are more functional while using their wheelchairs than they are without them, and clients say they are more successful when ATPs are involved with the CRT procurement process than when ATPs are not involved.

U.S. Rehab Refreshes FMA Dashboard
The new dashboard will have enhanced ease-of-use, more clearly defined graphics and menu selections, advanced diagnoses choices and more up-to-date demographic selections.